Qian Chen

Dr. Qian Chen


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
ZCZhigao Chen
Zhigao Chen
MYMin Yin
Min Yin
HJHaixue Jia
Haixue Jia
QCQian Chen
Qian Chen
HZHongbing Zhang
Hongbing Zhang
Augmentation of endogenous double-stranded RNA (dsRNA) has become a promising strategy for activating anti-tumor immunity through induction of type I interferon (IFN) in the treatment of ovarian carcinoma. However, the underlying regulatory mechanisms of dsRNA in ovarian carcinoma remain elusive. From The Cancer Genome Atlas (TCGA), we downloaded RNA expression profiles and clinical data of patients with ovarian carcinoma. Using the consensus clustering method, patients can be classified by their expression level of core interferon-stimulated genes (ISGs): IFN signatures high and IFN signatures low. The IFN signatures high group had a good prognosis. Gene set enrichment analysis (GSEA) showed that differentially expressed genes (DEGs) were primarily associated with anti-foreign immune responses. Based on results from protein-protein interaction (PPI) networks and survival analysis, ISG20 was identified as a key gene involved in host anti-tumor immune response. Further, elevated ISG20 expression in ovarian cancer cells led to increased IFN-β production. The elevated interferon improved the immunogenicity of tumor cells and generated chemokines that attract immune cells to infiltrate the area. Upon overexpression of ISG20, endogenous dsRNA accumulated in the cell and stimulated IFN-β production through the Retinoic acid-inducible gene I (RIG-I)-mediated dsRNA sense pathway. The accumulation of dsRNA was associated with the ribonuclease activity of ISG20. This study suggests that targeting ISG20 is a potential immune therapeutic approach to treat ovarian cancer.

12 February 2025 in Cancer Immunology, Immunotherapy
Verified
Journal Article
Open access
PDF file
ZRZhizhong Ren
Zhizhong Ren
YWYaqin Wang
Yaqin Wang
DJDandan Jiang
Dandan Jiang
YLYing Liu
Ying Liu
XYXiaowei Yang
Xiaowei Yang
YZYuewei Zhang
Yuewei Zhang
The effects of transarterial chemoembolization (TACE) on the systemic immune in hepatocellular carcinoma (HCC) are not well understood. We aimed to reveal the temporal and spatial changes in the immune profile of peripheral blood and tumor tissues in HCC patients following TACE. Eighty-four HCC patients were included, 20 of whom received TACE with a median follow-up of 28 months. Immune cell proportion within peripheral blood was profiled with flow cytometry, and therapeutic efficacy was evaluated by imaging examinations. Additionally, cell distribution within tumor microenvironment (TME) were compared between the necrotic tumor infiltration zone (N-IZ) and the residual tumor infiltration zone (R-IZ) by multiplex immunofluorescence. Among 20 patients, 25% (5/20) achieved complete response, and 75% (15/20) showed partial response. Fourteen patients received combinational targeted therapy and immunotherapy and the median progression-free survival was 15.5 months. Compared to healthy individuals, HCC exhibited significantly higher proportions of regulatory T cells (Tregs) and programmed death-1 receptor (PD1)+ Tregs within peripheral blood. PD1+ Treg cells, PD1+ CD4+ T cells and PD1+ CD8+ T cells decreased significantly within peripheral blood after TACE. In TME, N-IZ showed significantly lower CD4+ T, CD8+ T and FOXP3+ Tregs, higher PD1+ CD8+/CD8+ and PD1+ CD8+/ PD1+ FOXP3+. Moreover, the spatial distance between CD8+ T cells and the nearest FOXP3+ Tregs in N-IZ was significantly greater than in R-IZ. Our findings demonstrated that TACE could both remodel the immune components in peripheral blood and TME, strengthening the rationale for developing immunotherapy alongside TACE.

22 February 2023 in Applied Surface Science
Verified
Journal Article
Closed access
KWKaiwen Wang
Kaiwen Wang
YGYuhang Gao
Yuhang Gao
ZFZunlong Fang
Zunlong Fang
HLHui Li
Hui Li
RFRan Feng
Ran Feng
CWCong WANG
Cong WANG

10 September 2024 in Analytica Chimica Acta
Verified
Journal Article
Closed access
QZQi Zhang
Qi Zhang
BCBinbin Chen
Binbin Chen
QMQingbian Ma
Qingbian Ma
ZFZunlong Fang
Zunlong Fang
SLShu Li
Shu Li
Qiang MaQiang Ma
Qiang Ma

2 September 2024 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
YYYuanxun Yue
Yuanxun Yue
ZRZhizhong Ren
Zhizhong Ren
YWYaqin Wang
Yaqin Wang
YLYing Liu
Ying Liu
XYXiaowei Yang
Xiaowei Yang
YZYuewei Zhang
Yuewei Zhang
Background: Myeloid‐derived suppressor cells (MDSCs) play a pivotal role in immunosuppression and tumor progression in hepatocellular carcinoma (HCC). While various treatments like surgical resection, ablation, and radiotherapy have been studied for their effects on circulating MDSC frequencies in HCC patients, the findings remain inconclusive. Transarterial Chemoembolization (TACE) stands as the standard care for unresectable HCC, with Microparticle TACE (mTACE) gaining prominence for its capacity to induce significant tumor necrosis. However, the immunological ramifications of such pathological outcomes are scarcely reported.Methods and Results: This study aims to elucidate the alterations in MDSC subtypes, specifically monocytic MDSCs (mMDSCs) and early‐stage MDSCs (eMDSCs), post‐mTACE and to investigate their clinical correlations in HCC patients. A cohort comprising 75 HCC patients, 16 liver cirrhosis patients, and 20 healthy controls (HC) was studied. Peripheral blood samples were collected and analyzed for MDSC subtypes. The study also explored the associations between MDSC frequencies and various clinical parameters in HCC patients. The frequency of mMDSCs was significantly elevated in the HCC group compared to liver cirrhosis and HC. Importantly, mMDSC levels were strongly correlated with aggressive clinical features of HCC, including tumor size, vascular invasion, and distant metastasis. Post‐mTACE, a marked reduction in mMDSC frequencies was observed, while eMDSC levels remained stable.Conclusions: Our findings underscore the critical role of mMDSCs in HCC pathogenesis and their potential as a therapeutic target. The study also highlights the efficacy of mTACE in modulating the immunosuppressive tumor microenvironment, thereby opening new avenues for combinatorial immunotherapeutic strategies in HCC management.

8 November 2023 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
SZShaowen Zhang
Shaowen Zhang
PDPing Dong
Ping Dong
ZPZongwei Pan
Zongwei Pan
QCQian Chen
Qian Chen
JZJunqi Zhu
Junqi Zhu
ZMZhangfan Mao
Zhangfan Mao